SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-21-000052
Filing Date
2021-05-24
Accepted
2021-05-24 16:44:53
Documents
14
Period of Report
2021-05-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K supn-20210524.htm   iXBRL 8-K 35304
2 EX-99.1 ex99105-24x2021.htm EX-99.1 14600
6 logoa051.jpg GRAPHIC 5496
  Complete submission text file 0001356576-21-000052.txt   198897

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20210524.xsd EX-101.SCH 1927
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20210524_lab.xml EX-101.LAB 24274
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20210524_pre.xml EX-101.PRE 12658
7 EXTRACTED XBRL INSTANCE DOCUMENT supn-20210524_htm.xml XML 10780
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 21955614
SIC: 2834 Pharmaceutical Preparations